Arecor Therapeutics PLC
LSE:AREC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Arecor Therapeutics PLC
LSE:AREC
|
UK |
|
C
|
Church & Dwight Co Inc
LSE:0R13
|
US |
|
B
|
Babcock & Wilcox Enterprises Inc
F:UBW1
|
US |
|
Maxim Power Corp
TSX:MXG
|
CA |
|
D
|
DEME Group NV
F:MT0
|
BE |
|
S
|
Solaris Resources Inc
AMEX:SLSR
|
CA |
|
Royal Bank of Canada
TSX:RY
|
CA |
|
C
|
Check Point Software Technologies Ltd
SWB:CPW
|
IL |
|
K
|
KWG Group Holdings Ltd
F:KOU
|
CN |
|
B
|
BASF SE
XMUN:BAS
|
DE |
|
Emerald Resources NL
ASX:EMR
|
AU |
|
R
|
Regions Financial Corp
F:RN7
|
US |
|
D
|
DGA SA
WSE:DGA
|
PL |
|
T
|
Turning Point Brands Inc
F:0T5
|
US |
|
Biontech SE
NASDAQ:BNTX
|
DE |
|
H
|
Hilton Worldwide Holdings Inc
SWB:HI91
|
US |
|
W
|
Wesfarmers Ltd
OTC:WFAFF
|
AU |
|
Ultrajaya Milk Industry & Trading Company Tbk PT
IDX:ULTJ
|
ID |
|
Rolls-Royce Holdings PLC
OTC:RYCEF
|
UK |
Bankruptcy Probability
Arecor Therapeutics PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Arecor Therapeutics PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
A
|
Arecor Therapeutics PLC
LSE:AREC
|
27.4m GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
481.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Arecor Therapeutics PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Arecor Therapeutics PLC has total debt of 59k GBP. This includes both short-term (0 GBP) and long-term (59k GBP) debt.
You can find a full breakdown on its Balance Sheet.